Office will support rapid growth and collaboration with customers in China to accelerate biopharmaceutical R&D PRINCETON, N.J.—Nov. 9, 2020. Certara, a global leader in biosimulation, today announced the opening of a…
China’s NMPA now accepts CDISC submissions. To support this initiative, Pinnacle 21 has released a new Chinese-language validation engine.
Optimize your clinical trials with Certara’s Phase 1 Clinical Pharmacology Services. Comprehensive study design, execution, and regulatory support to ensure success.
Simcyp PBPK provides physiologically based pharmacokinetic modeling to predict drug behavior in diverse populations.
Tailored support to accelerate innovative gene and cell therapy programs with confidence.
Having the ability to scale with research needs is pivotal to success. Understanding when the time comes to automate processes can be challenging. This webinar will discuss data management practices…
Streamline aCRF formatting by mastering versions, repeated pages, and compliance essentials. Read the third blog in this series.
Without careful execution and the ability to navigate unexpected challenges, marketing application submissions are prone to falling off track and costing valuable time and resources
© 2025 Certara. All Rights Reserved. | Privacy policy
